Order Article Reprints

Paoletti G, Pepys J, Bragato MC, Paoletti S, Piona A, Messina MR, Racca F, Ferri S, Nappi E, Costanzo G, et al. The Prevalence of Immediate Hypersensitivity Reactions to the BNT162b2 mRNA Vaccine against SARS-CoV-2: Data from the Vaccination Campaign in a Large Academic Hospital. Vaccines. 2023; 11(5):903. https://doi.org/10.3390/vaccines11050903

Paoletti, Giovanni, Jack Pepys, Maria Chiara Bragato, Sandro Paoletti, Alessandra Piona, Maria Rita Messina, Francesca Racca, Sebastian Ferri, Emanuele Nappi, Giovanni Costanzo, and et al. 2023. "The Prevalence of Immediate Hypersensitivity Reactions to the BNT162b2 mRNA Vaccine against SARS-CoV-2: Data from the Vaccination Campaign in a Large Academic Hospital" Vaccines 11, no. 5: 903. https://doi.org/10.3390/vaccines11050903

Paoletti, G., Pepys, J., Bragato, M. C., Paoletti, S., Piona, A., Messina, M. R., Racca, F., Ferri, S., Nappi, E., Costanzo, G., Del Moro, L., Puggioni, F., Canonica, G. W., Azzolini, E., & Heffler, E. (2023). The Prevalence of Immediate Hypersensitivity Reactions to the BNT162b2 mRNA Vaccine against SARS-CoV-2: Data from the Vaccination Campaign in a Large Academic Hospital. Vaccines, 11(5), 903. https://doi.org/10.3390/vaccines11050903